Yanan Wang

990 total citations
55 papers, 716 citations indexed

About

Yanan Wang is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Yanan Wang has authored 55 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cancer Research, 26 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Yanan Wang's work include Cancer-related molecular mechanisms research (22 papers), MicroRNA in disease regulation (10 papers) and RNA modifications and cancer (8 papers). Yanan Wang is often cited by papers focused on Cancer-related molecular mechanisms research (22 papers), MicroRNA in disease regulation (10 papers) and RNA modifications and cancer (8 papers). Yanan Wang collaborates with scholars based in China and United States. Yanan Wang's co-authors include Fang Yin, Xiaojun Zhou, Chen Wu, Wufang Fan, Mao Luo, Yanli Tan, Shuang Qin, Bin Zhang, Lin Fang and Qixue Wang and has published in prestigious journals such as Cancer Research, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Yanan Wang

47 papers receiving 712 citations

Peers

Yanan Wang

ONCOL

PRM

IMMUN

Chenkai Ma Australia

Shuang Tao China

Guoyin Li China

Shengchun Wang China

Chengyou Jia China

Chunfa Chen China

Hanbin Chen China

Angelo Gámez‐Pozo Spain

Zhibin Liao China

Chenkai Ma Australia

Yanan Wang

518 ×1.1

319 ×0.9

144 ×0.9

ONCOL

106 ×1.1

PRM

56 ×0.8

IMMUN

Citations per year, relative to Yanan Wang Yanan Wang (= 1×) peers Chenkai Ma

Countries citing papers authored by Yanan Wang

Since Specialization

Citations

This map shows the geographic impact of Yanan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanan Wang more than expected).

Fields of papers citing papers by Yanan Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanan Wang. The network helps show where Yanan Wang may publish in the future.

Co-authorship network of co-authors of Yanan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yanan Wang. A scholar is included among the top collaborators of Yanan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanan Wang. Yanan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Liu, Weiguang Yang, Qingchao Li, et al.. (2025). ENPP1 promotes immune suppression, drug resistance, and adverse outcomes in bladder cancer: Potential for targeted therapy. Cancer Genetics. 294-295. 1–14.

Wang, Yanan, et al.. (2025). Anti-Müllerian hormone plays a bidirectional role in cancer: a multi-database and multi-method study. Discover Oncology. 16(1). 2124–2124.

Wang, Yanan, et al.. (2025). Mechanism of wetting by anionic surfactants with different polar groups on hydrophilic and hydrophobic nano-silica. Journal of Molecular Modeling. 31(6). 170–170. 4 indexed citations

Yang, Weiguang, et al.. (2025). JUN–ENPP1–cGAS–STING axis mediates immune evasion and tumor progression in bladder cancer. Journal of Translational Medicine. 23(1). 1222–1222. 1 indexed citations

Sun, Hang, Yan Wang, Minghao Sun, et al.. (2024). Developing Patient-Derived 3D-Bioprinting models of pancreatic cancer. Journal of Advanced Research. 74. 165–174. 5 indexed citations

Li, Zonglin, et al.. (2024). Exploring the clinical and biological significance of the cell cycle-related gene CHMP4C in prostate cancer. BMC Medical Genomics. 17(1). 210–210.

Zheng, Meng, Qingfeng Liu, Hua Zhang, et al.. (2024). Development of a Specifically Labeled ⁸⁹Zr Antibody for the Noninvasive Imaging of Tumors Overexpressing B7-H3. Molecular Pharmaceutics. 21(10). 5205–5216. 2 indexed citations

Chen, Liangqi, Meiju Zhang, Yanan Wang, et al.. (2024). Methyl-CpG-binding 2 K271 lactylation-mediated M2 macrophage polarization inhibits atherosclerosis. Theranostics. 14(11). 4256–4277. 31 indexed citations

Zhang, Min, Zhiming Liu, Ming Shen, et al.. (2023). Ferrostatin-1 attenuates hypoxic-ischemic brain damage in neonatal rats by inhibiting ferroptosis. Translational Pediatrics. 12(11). 1944–1970. 14 indexed citations

10.

Ding, Yan, Fan Yang, Yanan Wang, et al.. (2023). Multi-center study on predicting breast cancer lymph node status from core needle biopsy specimens using multi-modal and multi-instance deep learning. npj Breast Cancer. 9(1). 58–58. 8 indexed citations

11.

Liu, Bo, Wenzhe Li, Yanan Wang, et al.. (2023). LINC01278 Induces Autophagy to Inhibit Tumour Progression by Suppressing the mTOR Signalling Pathway. Oxidative Medicine and Cellular Longevity. 2023. 1–22. 6 indexed citations

12.

Wang, Yanan, et al.. (2022). An exploratory study on TCM syndrome differentiation in preoperative patients with colorectal cancer assisted by laboratory indicators. Heliyon. 8(8). e10207–e10207. 8 indexed citations

13.

Hong, Lei, et al.. (2022). Colorectal leiomyosarcoma with BRCA2 mutation benefit from treatment with olaparib: a case report. Journal of Gastrointestinal Oncology. 13(3). 1499–1504. 3 indexed citations

14.

Li, Xiaodong, et al.. (2022). Correlation between PET/CT findings and pathological features of mediastinal lymph nodes in non-small cell lung cancer. Minerva Medica. 113(3). 586–588. 1 indexed citations

15.

Wang, Xinran, Liang Wang, Hong Bu, et al.. (2021). How can artificial intelligence models assist PD-L1 expression scoring in breast cancer: results of multi-institutional ring studies. npj Breast Cancer. 7(1). 61–61. 31 indexed citations

16.

Sun, Jun, Dong He, Yibing Fu, et al.. (2021). A novel lncRNA ARST represses glioma progression by inhibiting ALDOA-mediated actin cytoskeleton integrity. Journal of Experimental & Clinical Cancer Research. 40(1). 187–187. 32 indexed citations

17.

Fang, Lin, et al.. (2021). Long Noncoding RNAs as Emerging Regulators of COVID-19. Frontiers in Immunology. 12. 700184–700184. 37 indexed citations

18.

Chen, Luyue, Junhu Zhou, Qixue Wang, et al.. (2020). TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma. Cancer Biology and Medicine. 17(3). 664–675. 5 indexed citations

19.

Wang, Yanan, et al.. (2019). MicroRNA-575 regulates development of gastric cancer by targeting PTEN. Biomedicine & Pharmacotherapy. 113. 108716–108716. 37 indexed citations

20.

Wang, Yanan, Aimin Zang, Yanhong Shang, et al.. (2018). Inducible T-cell co-stimulators regulate the proliferation and invasion of human hepatocellular carcinoma HepG2 cells. Biological Research. 51(1). 2–2. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact